Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Enhanced betatrophin and type 1 diabetes research via sample preparation reagent AlbuVoid™The article titled, “Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes” utilized AlbuVoid™’s albumin depletion protocol for removing albumin from plasma samples
By: Biotech Support Group For detailed protocols of the published article click http://link.springer.com/ Characteristics of AlbuVoid™ Albumin voids in flow-through >95%, with <30 minute bind/wash/elute protocol Low abundance enrichment equivalent or better than hexa-peptides or antibodies Disposable, cost-effective, no column regeneration or cross-contamination Mild elution maintains tertiary structure and simple transfer to secondary analysis The eluted fractions retain their enzymatic and biological activity Removes albumin from many species including human, mouse, sheep, bovine, goat, rat, calf, cell culture. The eluted fraction is compatible with LC-MS, activity based protein profiling and proteomic studies. About Biotech Support Group LLC Biotech Support Group LLC is a leading developer of proteomic and genomic sample preparation and enrichment products. It’s principal products include: AlbuVoid™ for albumin depletion, Cleanascite™ Contact: Dr. Swapan Roy Biotech Support Group 732-274-2866 sales@biotechsupportgroup.com http://www.biotechsupportgroup.com Reference Espes, Daniel, Joey Lau, and Per-Ola Carlsson. "Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes." Diabetologia( End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|